These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2781533)

  • 1. A new assay for the determination of factor XII in plasma using a chromogenic substrate and a selective inhibitor of plasma kallikrein.
    Stürzebecher J; Svendsen L; Eichenberger R; Markwardt F
    Thromb Res; 1989 Sep; 55(6):709-15. PubMed ID: 2781533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
    Tans G; Janssen-Claessen T; Rosing J; Griffin JH
    Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay for Hageman factor (factor XII) in human plasma by means of chromogenic substrate for plasma kallikrein.
    Egberg N; Overmark-Berggren I
    Thromb Res; 1983 Sep; 31(6):875-80. PubMed ID: 6557688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor XII assay with the chromogenic substrate chromozym PK.
    Dick W; Cullmann W; Müller N; Adler K
    J Clin Chem Clin Biochem; 1981 Jun; 19(6):357-61. PubMed ID: 6168728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.
    Tankersley DL; Alving BM; Finlayson JS
    Blood; 1983 Aug; 62(2):448-56. PubMed ID: 6191802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody F1 binds to the kringle domain of factor XII and induces enhanced susceptibility for cleavage by kallikrein.
    Ravon DM; Citarella F; Lubbers YT; Pascucci B; Hack CE
    Blood; 1995 Dec; 86(11):4134-43. PubMed ID: 7492770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of an association between factor XII and kallikrein in human plasma--significance of storage of plasma and the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1992 May; 66(4):421-34. PubMed ID: 1412207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assay of factor XII in human plasma using prekallikrein or the chromogenic peptide S-2222 as substrates--significance of the functional state of plasma kallikrein.
    Hoem NO; Johannesen S; Briseid K
    Thromb Res; 1989 May; 54(3):197-205. PubMed ID: 2787541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on synthetic peptide substrates for F XII enzymes.
    Friberger P; Aurell L; Rees W; Gallimore MJ
    Adv Exp Med Biol; 1986; 198 Pt B():53-61. PubMed ID: 3643740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of factor XII in acetone-treated human plasma: significance of the functional state of plasma kallikrein for the extent of activation.
    Hoem NO; Briseid K
    Acta Pharmacol Toxicol (Copenh); 1986 Aug; 59(2):144-50. PubMed ID: 3490738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chromogenic substrate assay kit for factor XII: evaluation and use for the measurement of factor XII levels in cardiopulmonary bypass patients.
    Gallimore MJ; Jones DW; Wendel HP
    Thromb Res; 1999 Apr; 94(2):103-9. PubMed ID: 10230895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional correlation between kallikrein and factor XII activated in human plasma.
    Briseid K; Hoem NO; Johannesen S; Marthinsen K
    Thromb Res; 1990 Mar; 57(6):945-56. PubMed ID: 1696402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of factor XII and plasma prekallikrein with chromozym PK].
    Stürzebecher J; Klessen C; Markwardt F
    Z Med Lab Diagn; 1982 Oct; 23(5):306-11. PubMed ID: 6924817
    [No Abstract]   [Full Text] [Related]  

  • 14. Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein "like" activity in human plasma.
    Gallimore MJ; Friberger P
    Thromb Res; 1982 Feb; 25(3):293-8. PubMed ID: 6917564
    [No Abstract]   [Full Text] [Related]  

  • 15. An optimized assay for prekallikrein activator activity in human plasma products.
    Tölö H; Suomela H
    Thromb Res; 1982 Jul; 27(1):35-44. PubMed ID: 6981866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct assay of factor XIIa in plasma with synthetic chromogenic substrates.
    Kluft C; Svendsen L; Los P
    Adv Exp Med Biol; 1983; 156():201-4. PubMed ID: 6190367
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanism of surface-mediated activation of bovine Factor XII and prekallikrein.
    Sugo T; Ohno Y; Shimada T; Kato H; Iwanaga S
    Adv Exp Med Biol; 1983; 156():87-107. PubMed ID: 6602465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of factor XII in plasma using the kallikrein substrate chromozym PK.
    Klessen C; Stürzebecher J; Markwardt F
    Thromb Res; 1982 Mar; 25(6):501-5. PubMed ID: 6921902
    [No Abstract]   [Full Text] [Related]  

  • 19. A microtitre chromogenic substrate assay for factor XII.
    Walshe KJ; Mackie IJ; Gallimore M; Machin SJ
    Thromb Res; 1987 Aug; 47(3):365-71. PubMed ID: 3629562
    [No Abstract]   [Full Text] [Related]  

  • 20. Factor XII fragment and kallikrein generation in plasma during incubation with biomaterials.
    van der Kamp KW; van Oeveren W
    J Biomed Mater Res; 1994 Mar; 28(3):349-52. PubMed ID: 7521336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.